In vivo visualization of metastatic prostate cancer and quantitation of disease progression in immunocompromised mice

Linda M. Kalikin, Abraham Schneider, Melissa A. Thakur, Yaron Fridman, Laura B. Griffin, Rodney L. Dunn, Thomas J. Rosol, Rajal B. Shah, Alnawaz Rehemtulla, Laurie K. McCauley, Kenneth J. Pienta

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

While survival periods for patients with localized prostate cancer have increased, there is still no curative therapy for metastatic disease. Using non-invasive bioluminescent imaging, we designed a comprehensive murine model to monitor tumor location and expansion. We detected micrometastases after one week that correlated by gross necropsy, autoradiography, and histopathology with organ and skeletal lesions seen clinically. We calculated in vivo kinetics for tumor growth based on biophoton emissions and observed significantly faster growth of bone lesions and of overall tumor burden in young mice compared to old mice. This model provides a controllable biological system for further investigation into the pathogenesis of metastatic prostate cancer and evaluation of new therapies.

Original languageEnglish (US)
Pages (from-to)17-21
Number of pages5
JournalCancer Biology and Therapy
Volume2
Issue number6
DOIs
StatePublished - Nov 1 2003
Externally publishedYes

Fingerprint

Disease Progression
Prostatic Neoplasms
Neoplasm Micrometastasis
Bone Development
Tumor Burden
Autoradiography
Neoplasms
Survival
Therapeutics
Growth

Keywords

  • Bioluminescence
  • Growth kinetics
  • Luciferase
  • Metastasis
  • PC-3
  • Prostate cancer
  • Xenograft model

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Cite this

Kalikin, L. M., Schneider, A., Thakur, M. A., Fridman, Y., Griffin, L. B., Dunn, R. L., ... Pienta, K. J. (2003). In vivo visualization of metastatic prostate cancer and quantitation of disease progression in immunocompromised mice. Cancer Biology and Therapy, 2(6), 17-21. https://doi.org/10.4161/cbt.2.6.531

In vivo visualization of metastatic prostate cancer and quantitation of disease progression in immunocompromised mice. / Kalikin, Linda M.; Schneider, Abraham; Thakur, Melissa A.; Fridman, Yaron; Griffin, Laura B.; Dunn, Rodney L.; Rosol, Thomas J.; Shah, Rajal B.; Rehemtulla, Alnawaz; McCauley, Laurie K.; Pienta, Kenneth J.

In: Cancer Biology and Therapy, Vol. 2, No. 6, 01.11.2003, p. 17-21.

Research output: Contribution to journalArticle

Kalikin, LM, Schneider, A, Thakur, MA, Fridman, Y, Griffin, LB, Dunn, RL, Rosol, TJ, Shah, RB, Rehemtulla, A, McCauley, LK & Pienta, KJ 2003, 'In vivo visualization of metastatic prostate cancer and quantitation of disease progression in immunocompromised mice', Cancer Biology and Therapy, vol. 2, no. 6, pp. 17-21. https://doi.org/10.4161/cbt.2.6.531
Kalikin, Linda M. ; Schneider, Abraham ; Thakur, Melissa A. ; Fridman, Yaron ; Griffin, Laura B. ; Dunn, Rodney L. ; Rosol, Thomas J. ; Shah, Rajal B. ; Rehemtulla, Alnawaz ; McCauley, Laurie K. ; Pienta, Kenneth J. / In vivo visualization of metastatic prostate cancer and quantitation of disease progression in immunocompromised mice. In: Cancer Biology and Therapy. 2003 ; Vol. 2, No. 6. pp. 17-21.
@article{8f6b778a16aa4fdb91816dc087209704,
title = "In vivo visualization of metastatic prostate cancer and quantitation of disease progression in immunocompromised mice",
abstract = "While survival periods for patients with localized prostate cancer have increased, there is still no curative therapy for metastatic disease. Using non-invasive bioluminescent imaging, we designed a comprehensive murine model to monitor tumor location and expansion. We detected micrometastases after one week that correlated by gross necropsy, autoradiography, and histopathology with organ and skeletal lesions seen clinically. We calculated in vivo kinetics for tumor growth based on biophoton emissions and observed significantly faster growth of bone lesions and of overall tumor burden in young mice compared to old mice. This model provides a controllable biological system for further investigation into the pathogenesis of metastatic prostate cancer and evaluation of new therapies.",
keywords = "Bioluminescence, Growth kinetics, Luciferase, Metastasis, PC-3, Prostate cancer, Xenograft model",
author = "Kalikin, {Linda M.} and Abraham Schneider and Thakur, {Melissa A.} and Yaron Fridman and Griffin, {Laura B.} and Dunn, {Rodney L.} and Rosol, {Thomas J.} and Shah, {Rajal B.} and Alnawaz Rehemtulla and McCauley, {Laurie K.} and Pienta, {Kenneth J.}",
year = "2003",
month = "11",
day = "1",
doi = "10.4161/cbt.2.6.531",
language = "English (US)",
volume = "2",
pages = "17--21",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "6",

}

TY - JOUR

T1 - In vivo visualization of metastatic prostate cancer and quantitation of disease progression in immunocompromised mice

AU - Kalikin, Linda M.

AU - Schneider, Abraham

AU - Thakur, Melissa A.

AU - Fridman, Yaron

AU - Griffin, Laura B.

AU - Dunn, Rodney L.

AU - Rosol, Thomas J.

AU - Shah, Rajal B.

AU - Rehemtulla, Alnawaz

AU - McCauley, Laurie K.

AU - Pienta, Kenneth J.

PY - 2003/11/1

Y1 - 2003/11/1

N2 - While survival periods for patients with localized prostate cancer have increased, there is still no curative therapy for metastatic disease. Using non-invasive bioluminescent imaging, we designed a comprehensive murine model to monitor tumor location and expansion. We detected micrometastases after one week that correlated by gross necropsy, autoradiography, and histopathology with organ and skeletal lesions seen clinically. We calculated in vivo kinetics for tumor growth based on biophoton emissions and observed significantly faster growth of bone lesions and of overall tumor burden in young mice compared to old mice. This model provides a controllable biological system for further investigation into the pathogenesis of metastatic prostate cancer and evaluation of new therapies.

AB - While survival periods for patients with localized prostate cancer have increased, there is still no curative therapy for metastatic disease. Using non-invasive bioluminescent imaging, we designed a comprehensive murine model to monitor tumor location and expansion. We detected micrometastases after one week that correlated by gross necropsy, autoradiography, and histopathology with organ and skeletal lesions seen clinically. We calculated in vivo kinetics for tumor growth based on biophoton emissions and observed significantly faster growth of bone lesions and of overall tumor burden in young mice compared to old mice. This model provides a controllable biological system for further investigation into the pathogenesis of metastatic prostate cancer and evaluation of new therapies.

KW - Bioluminescence

KW - Growth kinetics

KW - Luciferase

KW - Metastasis

KW - PC-3

KW - Prostate cancer

KW - Xenograft model

UR - http://www.scopus.com/inward/record.url?scp=79960785065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960785065&partnerID=8YFLogxK

U2 - 10.4161/cbt.2.6.531

DO - 10.4161/cbt.2.6.531

M3 - Article

C2 - 14688471

AN - SCOPUS:79960785065

VL - 2

SP - 17

EP - 21

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 6

ER -